Viral immune evasion: A masterpiece of evolution

Immunogenetics

Volumn 54, Issue 8, 2002, Pages 527-542

  Vossen, Mireille T M ^a   Westerhout, Ellen M ^b   Söderberg Nauclér, Cécilia ^c   Wiertz, Emmanuel J H J ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antigen presentation; Human cytomegalovirus; Immune evasion; Lymphocytes; Virus

Indexed keywords

CARRIER PROTEIN; EPITOPE; G PROTEIN COUPLED RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEASOME; TAPASIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; APOPTOSIS; CELLULAR IMMUNITY; CLEARANCE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DENDRITIC CELL; DOWN REGULATION; EFFECTOR CELL; ENZYME DEGRADATION; HERPES VIRUS; HUMAN; HUMORAL IMMUNITY; INFECTION RESISTANCE; INFECTION SENSITIVITY; LATENT VIRUS INFECTION; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; SUPERINFECTION; T LYMPHOCYTE; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; APOPTOSIS; COMPLEMENT ACTIVATION; CYTOKINES; EVOLUTION; IMMUNITY; IMMUNITY, CELLULAR; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; SUPERINFECTION; VIRUS DISEASES; VIRUSES;

HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 0036449295     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-002-0493-1     Document Type: Review

References (198)

1. Abendroth A, Slobedman B, Lee E, Mellins E, Wallace M, Arvin AM (2000) Modulation of major histocompatibility class II protein expression by Varicella-Zoster virus. J Virol 74:1900-1907
2. Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin AM (2001) Varicella-Zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol 75:4878-4888
3. Ablashi DV, Lusso P, Hung CL, Salahuddin SZ, Josephs SF, Llana T, Kramarsky B, Biberfeld P, Markham PD, Gallo RC (1988) Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpes-virus 6). Int J Cancer 42:787-791
4. Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Früh K (1996a) Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 93:10990-10995
5. Ahn K, Meyer TH, Uebel S, Sempé P, Djaballah H, Yang Y, Peterson PA, Früh K, Tampé R (1996b) Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J 15:3247-3255
6. Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, Ploegh HL, Peterson PA, Yang Y, Früh K (1997) The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613-621
7. Ambagala AP, Hinkley S, Srikumaran S (2000) An early pseudorabies virus protein downregulates porcine MHC class I expression by inhibition of transporter associated with antigen processing (TAP). J Immunol 164:93-99
8. Andersson M, Pääbo S, Nilsson T, Peterson PA (1985) Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43:215-222
9. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA (2001) Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2:1077-1084
10. Androlewicz MJ, Anderson KS, Cresswell P (1993) Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci USA 90:9130-9134
11. Arrigo AP, Tanaka K, Golberg AL, Welch WJ (1988) Identity of the 19S 'prosome' particle with the large multifunctional pro-tease complex of mammalian cells (the proteasome). Nature 331:192-194
12. +T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells. J Virol 76:142-150
13. Baggiolini M, Dahinden CA (1994) CC chemokines in allergic inflammation. Immunol Today 15:127-133
14. + cytotoxic T lymphocytes responses to lentiviruses and herpesviruses. Curr Opin Immunol 13:479-482
15. Baucke RB, Spear PG (1979) Membrane proteins specified by herpes simplex viruses. Identification of an Fc-binding glycoprotein. J Virol 32:779-789
16. Beck S, Barrell BG (1988) Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature 331:269-272
17. Beisser PS, Vink C, van Dam JG, Grauls G, Vanherle SJ, Bruggeman CA (1998) The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. J Virol 72:2352-2363
18. Beisser PS, Grauls G, Bruggeman CA, Vink C (1999) Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain. J Virol 73:7218-7230
19. Beisser PS, Laurent L, Virelizier JL, Michelson S (2001) Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 Monocytes. J Virol 75:5949-5957
20. Bennett EM, Bennink JR, Yewdell JW, Brodsky FM (1999) Ade-novirus E19 has two mechanisms for affecting class I MHC expression. J Immunol 162:5049-5052
21. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, Fiaccadori F, Ferrari C (1994) Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-410
22. Biesinger B, Tsygankov AY, Fickenscher H, Emmrich F, Fleckenstein B, Bolen JB, Broker BM (1995) The product of the herpes virus saimiri open reading frame 1 (tip) interacts with T cell-specific kinase p561ck in transformed cells. J Biol Chem 270:4729-4734
23. Billstrom MA, Johnson GL, Avdi NJ, Worthen GS (1998) Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection. J Virol 72:5535-5544
24. Blery M, Olcese L, Vivier E (2000) Early signaling via inhibitory and activating NK receptors. Hum Immunol 61:51-64
25. Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L, Arenzana-Seisdedos F, Virelizier JL, Michelson S (1998) Chemokine sequestration by viral chemoreceptors as a novel escape strategy: Withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188:855-866
26. Borza CM, Hutt-Fletcher LM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8:594-599
27. Bokoch GM (1995) Chemoattractant signaling and leukocyte activation. Blood 86:1649-1660
28. 2 microglobulin. Nature 347:770-772
29. Buchmeier NA, Cooper NR (1989) Suppression of monocyte functions by human cytomegalovirus. Immunology 66:278-283
30. Burgert HG, Kvist S (1985) An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987-997
31. Casarosa P, Bakker RA, Verzijl D, Navis M, Timmerman H, Leurs R, Smit MJ (2001) Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J Biol Chem 276:1133-1137
32. Chapman TL, Bjorkman PJ (1998) Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homologue: Comparison to MHC molecules and to the human cytomegalovirus MHC homologue. J Virol 72:460-466
33. Chapman TL, Heikeman AP, Bjorkman PJ (1999) The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homologue UL18. Immunity 11:603-613
34. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, Horsnell T, Hutchinson III CA, Kouzarides T, Martignetti JA, Preddie E, Satchwell SC, Tomlinson P, Weston KM, Barrell BG (1990a) Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154:125-169
35. Chee MS, Satchwell SC, Preddie E, Weston KM, Barrell BG (1990b) Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature 344:774-777
36. Chen M, Popescu N, Woodworth C, Berneman Z, Corbellino M, Lusso P, Ablashi DV, DiPaolo JA (1994) Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression. J Virol 68:1173-1178
37. Chen BK, Gandhi RT, Baltimore D (1996) CD4 downmodulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities ofvpu, env and nef. J Virol 70:6044-6053
38. Claas EC, Osterhaus AD (1998) New clues to the emergence of flu pandemics. Nat Med 4:1122-1123
39. Colonna M, Nakajima H, Cella M (1999) Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells. J Leukoc Biol 66:718-722
40. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273-282
41. Cosman D, Fanger N, Borges L (1999) Human cytomegalovirus MHC class I and inhibitory signaling receptors: More questions than answers. Immunol Rev 168:177-185
42. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123-133
43. Davis-Poynter NJ, Lynch DM, Vally H, Shellam GR, Rawlinson WD, Barrell BG, Farrell HE (1997) Identification and characterization of a G protein-coupled receptor homologue encoded by murine cytomegalovirus. J Virol 71:1521-1529
44. De Jong JC, Claas EC, Osterhaus AD, Webster RG, Lim WL (1997) A pandemic warning? Nature 389:554
45. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991a) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220
46. De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE (1991b) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915-924
47. Dubin G, Socolof E, Frank I, Friedman HM (1991) Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol 65:7046-7050
48. Erpel T, Courtneidge SA (1995) Src family protein kinases and cellular signal transduction pathways. Curr Opin Cell Biol 7:176-182
49. Evans CH (1996) Cytokines and viral anti-immune genes. Stem Cells 14:177-184
50. Fahnestock ML, Johnson JL, Feldman RM, Neveu JM, Lane WS, Bjorkman PJ (1995) The MHC class I homologue encoded by human cytomegalovirus binds endogenous peptides. Immunity 3:583-590
51. Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ (1997) Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386:510-514
52. Flamand L, Stefanescu I, Ablashi DV, Menezes J (1993) Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol 67:6768-6777
53. Foster GR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC, Stark GR (1991) Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc Natl Acad Sci USA 88:2888-2892
54. Frenkel N, Wyatt LS (1992) HHV-6 and HHV-7 as exogenous agents in human lymphocytes. Dev Biol Stand 76:259-265
55. Friedman HM, Cohen GJ, Eisenberg RJ, Seidel CA, Cines DB (1984) Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 309:633-635
56. Früh K, Ahn K, Djaballah H, Sempé P, van Endert PM, Tampé R, Peterson PA, Yang Y (1995) A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415-418
57. Fujita K, Maldarelli F, Silver J (1996) Bimodal down-regulation of CD4 in cells expressing human immunodeficiency virus type 1 Vpu and Env. J Gen Virol 77:2393-2401
58. Furman MH, Ploegh HL, Tortorella D (2002) Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules. J Biol Chem 277:3258-3267
59. Furukawa T, Hornberger E, Sakuma S, Plotkin SA (1975) Demonstration of immunoglobulin G receptors induced by human cytomegalovirus. J Clin Microbiol 2:332-336
60. +T cells. J Immunol 152:5768-5775
61. Gao JL, Murphy PM (1994) Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem 269:28539-28542
62. Gewurz BE, Gaudet R, Tortorella D, Wang EW, Ploegh HL, Wiley DC (2001a) Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc Natl Acad Sci USA 98:6794-6799
63. Gewurz BE, Wang EW, Tortorella D, Schust DJ, Ploegh HL (2001b) Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner. J Virol 75:5197-5204
64. Gilbert MJ, Riddell SR, Li CR, Greenberg PD (1993) Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J Virol 67:3461-3469
65. Gilbert MJ, Riddell SR, Plachter B, Greenberg PD (1996) Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 383:720-722
66. Glynne R, Powis SH, Beck S, Kelly A, Kerr LA, Trowsdale J (1991) A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353:357-360
67. Gooding LR, Sofola IO, Tollefson AE, Duerksen-Hughes P, Wold WS (1990) The adenovirus E3-14.7k protein is a general inhibitor of tumor necrosis factor mediated cytolysis. J Immunol 145:3080-3086
68. Gorman OT, Bean WJ, Webster RG (1992) Evolutionary processes in influenza viruses: Divergence, rapid evolution and stasis. Curr Top Microbiol Immunol 176:75-97
69. Harris SL, Frank I, Yee A, Cohen GH, Eisenberg RJ, Friedman HM (1990) Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J Infect Dis 162:331-337
70. +T cell effector mechanisms in resistance to infection. Annu Rev Immunol 18:275-308
71. Heise MT, Connick M, Virgin HW 4th (1998) Murine cytomegalovirus inhibits interferon-gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of MHC class II-associated genes. J Exp Med 187:1037-1046
72. Hengel H, Koopmann JO, Flohr T, Muranyi W, Goulmy E, Hämmerling GJ, Koszinowski UH, Momburg F (1997) A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6:623-632
73. Hewitt EW, Gupta SS, Lehner PJ (2001) The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J 20:387-396
74. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-415
75. Hinkley S, Hill AB, Srikumaran S (1998) Bovine herpesvirus-1 infection affects the peptide transport activity in bovine cells. Virus Res 53:91-96
76. Holland G, Zlotnik A (1993) Interleukin 10 and cancer. Cancer Invest 11:751-758
77. Hou S, Guan H, Ricciardi RP (2002) In adenovirus type 12 tumorigenic cells, major histocompatibility complex class I transcription shutoff is overcome by induction of NF-κB and relief of COUP-TFII repression. J Virol 76:3212-3220
78. Howcroft TK, Strebel K, Martin MA, Singer DS (1993) Repression of MHC class I gene promotor activity by two-exon Tat of HIV. Science 260:1320-1322
79. Huard B, Früh K (2000) A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells. Eur J Immunol 30:509-515
80. Hudson AW, Howley PM, Ploegh HL (2001) A human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomes. J Virol 75:12347-12358
81. Hughes EA, Hammond C, Cresswell P (1997) Misfolded major histocompatibility complex class I heavy chain are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci USA 94:1896-1901
82. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schröter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195
83. Ishido S, Wang C, Lee BS, Cohen GB, Jung JU (2000) Downregulation of major histocompatibility complex class I molecules by Karposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74:5300-5309
84. Jackson MR, Nilsson T, Peterson PA (1990) Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J 9:3153-3162
85. Johnson DC, Frame MC, Ligas MW, Cross AM, Stow ND (1988) Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol 62:1347-1354
86. Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL (1996) Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 93:11327-11333
87. Jung JU, Lang SM, Jun T, Roberts TM, Veillette A, Desrosiers RC (1995) Downregulation of Lck-mediated signal transduction by tip of herpes virus saimiri. J Virol 69:7814-7822
88. Kärre K (2002) Clever, cleverer, cleverest. Nat Immunol 3:505-506
89. Kavanagh DM, Gold MC, Wagner M, Koszinowski UH, Hill AB (2001) The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J Exp Med 194:967-978
90. Kelly A, Powis SH, Glynne R, Radley E, Beck S, Trowsdale J (1991) Second proteasome-related gene in the human MHC class II region. Nature 353:667-668
91. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, Zlotnik A (1994) Lymphotactin: A cytokine that represents a new class of chemokine. Science 266:1395-1399
92. Kerkau T, Bacik I, Bennink JR, Yewdell JW, Hünig T, Schimpl A, Schubert U (1997) The human immunodeficiency virus type-1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J Exp Med 185:1295-1305
93. Kikkert M, Hassink G, Barel M, Hirsch C, van der Wal FJ, Wiertz E (2001) Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol. Biochem J 358:369-377
94. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579-5588
95. 3C chemokine, fractal-kine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett 441:209-214
96. Klenerman P, Meier UC, Phillips RE, McMichael AJ (1995) The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur J Immunol 25:1927-1931
97. Koppelman B, Neefjes JJ, de Vries JE, de Waal Malefyt R (1997) Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7:861-871
98. Koppers-Lalic D, Rijsewijk FA, Verschuren SB, van Gaans-van den Brink JA, Neisig A, Ressing ME, Neefjes J, Wiertz EJ (2001) The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1. J Gen Virol 82:2071-2081
99. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S (2000) Human cytomegalovirus harbors its own unique IL-10 homologue (cmvIL-10). Proc Natl Acad Sci USA 97:1695-1700
100. +T cells and NK cells in vivo. Nat Immunol 3:529-535
101. Kuschner DB, Ricciardi RP (1999) Reduced phosphorylation of p50 is responsible for diminished NF-kappaB binding to the major histocompatibility complex class I enhancer in Adenovirus type 12-transformed cells. Mol Cell Biol 19:2169-2179
102. Lehner PJ, Wilkinson GW (2001) Cytomegalovirus: From evasion to suppression? Nat Immunol 2:993-994
103. Leong CC, Chapman TL, Bjorkman PJ, Formankova D, Mocarski ES, Phillips JH, Lanier LL (1998) Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: The role of endogenous class I major histocompatibility complex and a viral class I homologue. J Exp Med 187:1681-1687
104. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen 1. Nature 375:685-688
105. Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG (1997) Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 94:12616-12621
106. Lilley BN, Ploegh HL, Tirabassi RS (2001) Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol 75:11218-11221
107. Liu Y, Wei SH, de Waal Malefyt R, Moore KW (1994) Expression cloning and characterization of a human IL-10 receptor. J Immunol 152:1821-1829
108. Ljunggren HG, Kärre K (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11:237-244
109. Lorenzo ME, Jung JU, Ploegh HL (2002) Karposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class I major histocompatibility complexes to late endocytic compartments. J Virol 76:5522-5531
110. Lubinski J, Nagashunmugan T, Friedman HM (1998) Viral interference with antibody and complement. Semin Cell Dev Biol 9:329-337
111. +T lymphocytes by human herpesvirus 6. Nature 349:533-535
112. +mature human T cell populations and clones by human herpes virus 6. Transcriptional down-regulation of CD3. J Immunol 147:685-691
113. Machold RP, Wiertz EJ, Jones TR, Ploegh HJ (1997) The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med 185:363-366
114. Mangasarian A, Foti M, Aiken C, Chin D, Carpentier JL, Trono D (1997) The HIV-I Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity 6:67-77
115. Margottin F, Benichou S, Durand H, Richard V, Liu LX, Gomas E, Benarous R (1996) Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: Role of Vpu residues involved in CD4 interaction and in vitro degradation. Virology 223:381-386
116. Martin SJ, Green DR (1995) Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349-352
117. Martinez CK, Monaco JJ (1991) Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 353:664-667
118. Matthes T, Werner-Favre C, Tang H, Zhang X, Kindler V, Zubler RH (1993) Cytokine mRNA expression during an in vitro response of human B lymphocytes: Kinetics of B cell tumor necrosis factor alpha, interleukin (IL)-6, IL-10 and transforming growth factor beta 1 mRNAs. J Exp Med 178:521-528
119. McKenzie R, Kotwal GJ, Moss B, Hammer CH, Frank MM (1992) Regulation of complement activity by vaccinia virus complement-control protein. J Infect Dis 166:1245-1250
120. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794-2804
121. Miller CL, Lee JH, Kieff E, Burkhardt AL, Bolen JB, Longnecker R (1994) Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosinase kinases involved in sIg-mediated signal transduction. Infect Agents Dis 3:128-136
122. Miller CL, Burkhardt AL, Lee JH, Stealey B, Longnecker R, Bolen JB, Kieff E (1995) Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166
123. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman WJ, Sedmak DD (1998) Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 187:675-683
124. Miller DM, Zhang Y, Rahill BM, Waldman WJ, Sedmak DD (1999) Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 162:6107-6113
125. Molesworth SJ, Lake CM, Borza CM, Turk SM, Hutt-Fletcher LM (2000) Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J Virol 74:6324-6332
126. Murphy PM (1994a) The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12:593-633
127. Murphy PM (1994b) Molecular piracy of chemokine receptors by herpesviruses. Infect Agents Dis 3:137-154
128. Nagata S (1997) Apoptosis by death factor. Cell 88:355-365
129. Neefjes JJ, Momburg F, Hämmerling GH (1993) Selective and ATP-dependent translocation of peptide by the MHC-encoded transporter. Science 261:769-771
130. Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR (1987) Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: Sequence homology of gp350 and C3 complement fragment C3d. J Virol 61:1416-1420
131. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ (1993a) Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 268:12247-12249
132. Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ (1993b) Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72:415-425
133. Odeberg J, Söderberg-Nauclér C (2001) Reduced expression of HLA class II molecules and interleukin-10- and transforming growth factor â1-independent suppression of T cell proliferation in human cytomegalovirus-infected macrophage cultures. J Virol 75:5174-5181
134. Odeberg J, Cerboni C, Browne H, Karre K, Moller E, Carbone E, Söderberg-Nauclér C (2002) Human cytomegalovirus (HMCV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand J Immunol 55:149-161
135. Ossendorp F, Eggers M, Neisig A, Ruppert T, Groettrup M, Sijts A, Mengedé E, Kloetzel PM, Neefjes J, Koszinowski U, Melief C (1996) A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115-124
136. Pääbo S, Weber F, Kämpe O, Schaffner W, Peterson PA (1983) Association between transplantation antigens and a viral membrane protein synthesized from a mammalian expression vector. Cell 33:445-453
137. Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, Schall TJ (1999) Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci USA 96:9839-9844
138. Persson H, Jörnvall H, Zabielski J (1980) Multiple mRNA species for the precursor to an adenovirus-encoded glycoprotein: Identification and structure of the signal sequence. Proc Natl Acad Sci USA 77:6349-6353
139. Peter ME, Krammer PH (1998) Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10:545-551
140. Piguet V, Schwartz O, Le Gall S, Trono D (1999) The downregulation of CD4 and MHC-I by primate lentiviruses: A paradigm for the modulation of cell surface receptors. Immunol Rev 168:51-63
141. Pleskoff O, Treboute C, Brelot A, Heveker N, Seman M, Alizon M (1997) Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276:1874-1878
142. Pruett PS, Air GM (1998) Critical interactions in binding antibody NC41 to influenza N9 neuramidase: Amino acid contacts on the antibody heavy chain. Biochemistry 37:10660-10670
143. Pyeon D, O'Reilly KL, Splitter GA (1996) Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytic animals infected with bovine leukemia virus. J Virol 70:5706-5710
144. Rawlinson S, Farrell HE, Barrell BG (1996) Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70:8833-8849
145. Redpath S, Angulo A, Gascoigne NRJ, Ghazal P (1999) Murine cytomegalovirus infection downregulates MHC class II expression on macrophages by induction of IL-10. J Immunol 162:6701-6707
146. Rehm A, Engelsberg A, Tortorella D, Körner IJ, Lehmann I, Ploegh HL, Höpken UE (2002) Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells. J Virol 76:5043-5050
147. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH (1999) A cytomegalovirus glycoprotein reroutes MHC class I complexes to lysosomes for degradation. EMBO J 18:1081-1091
148. Reyburn HT, Mandelboim O, Valés-Gómez M, Davis DM, Pazmany L, Strominger JL (1997) The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514-517
149. Rosengard AM, Liu Y, Nie Z, Jimenez R (2002) Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement. Proc Natl Acad Sci USA 99:8808-8813
150. Rosenkilde MM, Waldhoer M, Lüttichau HR, Schwartz TW (2001) Virally encoded 7TM receptors. Oncogene 20:1582-1593
151. Rotem-Yeduhar R, Groettrup M, Soza A, Kloetzel PM, Ehrlich R (1996) LMP-associated proteolytic activities and TAP-dependent peptide transport for class I MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus type 12. J Exp Med 183:499-514
152. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P (1996) Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5:103-114
153. Sahu A, Isaacs SN, Soulika AM, Lambris JD (1998) Interaction of vaccinia virus complement control protein with human complement proteins: Factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J Immunol 160:5596-5604
154. Schmolke S, Kern HF, Drescher P, Jahn G, Plachter B (1995) The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J Virol 69:5959-5968
155. Scholz M, Hamann A, Blaheta RA, Auth MK, Encke A, Markus BH (1992) Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon gamma. Hum Immunol 35:230-238
156. Schubert U, Strebel K (1994) Differential activities of the human immunodeficiency virus type-1 encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J Virol 68:2260-2271
157. Schubert U, Antón LC, Bacík I, Cox JH, Bour S, Bennink JR, Orlowski M, Strebel K, Yewdell JW (1998) CD4 glycoprotein degradation induced by human immunodeficiency virus type I Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol 72:2280-2288
158. Schwartz O, Marechal V, LeGall S, Lemonnier F, Heard JM (1996) Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2:338-342
159. Sedmak DD, Chaiwiriyakul S, Knight DA, Waldman WJ (1995) The role of interferon beta in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells. Arch Virol 140:111-126
160. Senkevich TG, Bugert JJ, Sisler JR, Koonin EV, Darai G, Moss B (1996) Genome sequence of a human tumorigenic poxvirus: Prediction of specific host-response-evasion genes. Science 273:813-816
161. Shamu CE, Flierman D, Ploegh HL, Rapoport TA, Chau V (2001) Polyubiquitination is required for US11-dependent movement of MHC class I heavy chains from endoplasmatic reticulum into cytosol. Mol Biol Cell 12:2546-2555
162. Sharipo A, Imreh M, Leonchiks A, Brändén C-I, Masucci MG (2001) cis-inhibition of proteasomal degradation by viral repeats: Impact of length and amino acid composition. FEBS Lett 499:137-142
163. Shepherd JC, Schumacher TNM, Ashton-Rickerdt PG, Imaeda S, Ploegh HL, Janeway CA, Tonegawa S (1993) TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74:577-584
164. Shisler J, Yang C, Walter B, Ware CF, Gooding LR (1997) The adenovirus E3-10.4k/14.5k complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J Virol 71:8299-8306
165. Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, Miller NE, Jackson MR, Compton T, Früh K (2001) Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci USA 98:7140-7145
166. Smirnov DA, Hou S, Liu X, Claudio E, Siebenlist UK, Ricciardi RP (2001) COUP-TFII is upregulated in Adenovirus type 12 tumorigenic cells and is a repressor of MHC class I transcription. Virology 284:13-19
167. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-1023
168. Söderberg-Nauclér C, Fish KN, Nelson JA (1997a) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126
169. Söderberg-Nauclér C, Fish KN, Nelson JA (1997b) Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest 100:3154-3163
170. Söderberg-Nauclér C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP, Nelson JA (2001) Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol 75:7543-7554
171. Spencer JV, Lockridge KM, Barry PA, Lin G, Tsang M, Penfold ME, Schall TJ (2002) Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76:1285-1292
172. Streblow DN, Söderberg-Nauclér C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, Nelson JA (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99:511-520
173. Swaminathan S, Hesselton R, Sullivan J, Kieff E (1983) Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J Virol 67:7406-7413
174. Swann SA, Williams M, Story CM, Bobbitt KR, Fleis R, Collins KL (2001) HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway. Virology 282:267-277
175. Tanner J, Weis J, Fearon D, Whang Y, Kieff E (1987) Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50:203-213
176. Thäle R, Lucin P, Schneider K, Eggers M, Koszinowski UH (1994) Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol 68:7757-7765
177. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer J, Schröter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521
178. Tollefson AE, Hermison TW, Lichtenstein DL, Colle CF, Trip RA, Dimitrov T, Toth K, Wells CE, Doherty PC, Wold WS (1998) Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392:726-730
179. Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson WG (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031-1033
180. Tomazin R, Hill AB, Jugovic P, York I, van Endert P, Ploegh HL, Andrews DW, Johnson DC (1996) Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 15:3256-3266
181. + T cells. Nat Med 5:1039-1043
182. Tong X, Boll W, Kirchhausen T, Howley PM (1998) Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. J Virol 72: 476-482
183. Upton C, Macen JL, Schreiber M, McFadden G (1991) Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184:370-382
184. Upton C, Mossman K, McFadden G (1992) Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258:1369-1372
185. Van Endert R, Tampe R, Meyer TH, Tisch R, Bach JF, McDevitt HO (1994) A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1:491-500
186. Vanderplasschen A, Mathew E, Hollinshead M, Sim RB, Smith GL (1998) Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci USA 95:7544-7549
187. Vieira J, Schall TJ, Corey L, Geballe AP (1998) Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J Virol 72:8158-8165
188. Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL (1996a) Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432-438
189. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL (1996b) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-779
190. Wold WS, Hermiston TW, Tollefson AE (1994) Adenovirus proteins that subvert host defenses. Trends Microbiol 2:437-443
191. + T lymphocytes. Cell 77:525-535
192. + T cell clones and peripheral blood T cells. J Immunol 149:2378-2384
193. Zdanov A, Schalk-Hihi C, Menon S, Moore KW, Wlodawer A (1997) Crystal structure of Epstein-Barr virus protein BCRF1, a homologue of cellular interleukin-10. J Mol Biol 268:460-467
194. Zeidler R, Eissner G, Meissner P, Uebel S, Tampé R, Lazis S, Hammerschmidt W (1997) Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood 90:2390-2397
195. Zhuravskaya T, Maciejewski JP, Netski DM, Bruening E, Mackintosh FR, St Jeor S (1997) Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: Model of HCMV latency. Blood 90:2482-2491
196. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM, Salvesen GS (1997) Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J Biol Chem 272:7797-7800
197. Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T, Hengel H, Farrell H, Rawlinson W, Koszinowski UH (1997) A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6:57-66
198. Ziegler H, Muranyi W, Burgert HG, Kremmer E, Koszinowski UH (2000) The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules. EMBO J 19:870-881